- Home
- MTEK vs PYPD Comparison
MTEK vs PYPD Comparison
Compare MTEK & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEK
- PYPD
- Stock Information
- Founded
- MTEK 2008
- PYPD 2008
- Country
- MTEK Israel
- PYPD Israel
- Employees
- MTEK N/A
- PYPD N/A
- Industry
- MTEK
- PYPD Medical/Dental Instruments
- Sector
- MTEK
- PYPD Health Care
- Exchange
- MTEK Nasdaq
- PYPD Nasdaq
- Market Cap
- MTEK 17.6M
- PYPD 16.5M
- IPO Year
- MTEK 2022
- PYPD 2020
- Fundamental
- Price
- MTEK $4.42
- PYPD $2.93
- Analyst Decision
- MTEK
- PYPD Strong Buy
- Analyst Count
- MTEK 0
- PYPD 2
- Target Price
- MTEK N/A
- PYPD $12.00
- AVG Volume (30 Days)
- MTEK 337.8K
- PYPD 28.7K
- Earning Date
- MTEK 12-31-2024
- PYPD 02-12-2025
- Dividend Yield
- MTEK N/A
- PYPD N/A
- EPS Growth
- MTEK N/A
- PYPD N/A
- EPS
- MTEK N/A
- PYPD N/A
- Revenue
- MTEK $6,967,508.00
- PYPD N/A
- Revenue This Year
- MTEK N/A
- PYPD N/A
- Revenue Next Year
- MTEK N/A
- PYPD N/A
- P/E Ratio
- MTEK N/A
- PYPD N/A
- Revenue Growth
- MTEK 246.50
- PYPD N/A
- 52 Week Low
- MTEK $1.01
- PYPD $2.37
- 52 Week High
- MTEK $5.31
- PYPD $9.20
- Technical
- Relative Strength Index (RSI)
- MTEK 83.63
- PYPD 33.37
- Support Level
- MTEK $2.11
- PYPD $2.37
- Resistance Level
- MTEK $3.32
- PYPD $3.13
- Average True Range (ATR)
- MTEK 0.49
- PYPD 0.24
- MACD
- MTEK 0.18
- PYPD -0.06
- Stochastic Oscillator
- MTEK 73.19
- PYPD 19.30
About MTEK Maris-Tech Ltd.
Maris Tech Ltd is a provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.